Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study

Clinical trial NCT07739485 · RECRUITING

Trial details

NCT number: NCT07739485
Sponsor: Liu Shu
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple -Negative Breast Cancer

Start date: 2026-07-30
Primary completion: 2027-07-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.